Baxalta Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Deerfield IL United States (1931)
Status: Acquired by Shire (2016) → now Takeda (2018)

Organization Overview

First Clinical Trial
1997
NCT00003056
First NDA Approval
1951
mephentermine sulfate (wyamine sulfate)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Baxalta GmbH | Baxalta Innovations GmbH | Baxalta Japan Limited | Baxalta, now part of Shire | Baxalta US Inc. | Baxter | Baxter BioScience | Baxter (China) Investment Co. Ltd. | Baxter Deutschland GmbH | Baxter Healthcare | Baxter Healthcare Corporation | Baxter Healthcare International | BAXTER HLTHCARE | BAXTER HLTHCARE CORP | Baxter Innovations GmbH